Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB for Pain After Laparoscopic Renal Surgery
NCT02841982Completed
- Start
- Aug 2016
- Primary completion
- Nov 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain. Primary endpoint: cumulative morphine consumption at 48 hours. Started Aug 2016; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02841982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841982.